Pro Dex Inc financial data

Symbol
PDEX on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
2361 Mcgaw Avenue, Irvine, CA
Fiscal year end
June 30
Latest financial report
10-Q - Q3 2024 - Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 331 % +5.42%
Quick Ratio 137 % -13%
Debt-to-equity 91 % +0.3%
Return On Equity 22.5 % -0.88%
Return On Assets 9.98 % -2.73%
Operating Margin 14.7 % +3.89%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.36M shares -5.34%
Common Stock, Shares, Outstanding 3.3M shares -7.04%
Entity Public Float 35.5M USD +9.23%
Common Stock, Value, Issued 1.46M USD -79.1%
Weighted Average Number of Shares Outstanding, Basic 3.26M shares -8.09%
Weighted Average Number of Shares Outstanding, Diluted 3.29M shares -7.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 56.8M USD +21%
Cost of Revenue 40.8M USD +21.7%
Research and Development Expense 3.23M USD +20.4%
General and Administrative Expense 4.32M USD +8.1%
Operating Income (Loss) 8.35M USD +25.7%
Nonoperating Income (Expense) 485K USD -52.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6.78M USD -4.88%
Income Tax Expense (Benefit) 1.57M USD -16%
Net Income (Loss) Attributable to Parent 5.21M USD -0.91%
Earnings Per Share, Basic 1.54 USD/shares +4.05%
Earnings Per Share, Diluted 1.52 USD/shares +4.83%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.08M USD +61.8%
Marketable Securities, Current 4.74M USD +369%
Accounts Receivable, after Allowance for Credit Loss, Current 13.5M USD +22%
Inventory, Net 16.6M USD +2.09%
Assets, Current 38.5M USD +22.5%
Deferred Income Tax Assets, Net 1.56M USD
Property, Plant and Equipment, Net 5.18M USD +4.67%
Operating Lease, Right-of-Use Asset 1.37M USD -22.8%
Intangible Assets, Net (Excluding Goodwill) 47K USD -37.3%
Other Assets, Noncurrent 44K USD +4.76%
Assets 54.3M USD +9.53%
Accounts Payable, Current 4.44M USD +62.1%
Accrued Liabilities, Current 4.02M USD +48.8%
Liabilities, Current 11.3M USD +36.3%
Long-term Debt and Lease Obligation 10.6M USD -9.64%
Accrued Income Taxes, Noncurrent 1.16M USD -3.56%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 1.06M USD -30.5%
Liabilities 23.4M USD +27.4%
Retained Earnings (Accumulated Deficit) 29.4M USD +21.5%
Stockholders' Equity Attributable to Parent 30.9M USD -1.02%
Liabilities and Equity 54.3M USD +9.53%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.89M USD +381%
Net Cash Provided by (Used in) Financing Activities -1.01M USD +22.5%
Net Cash Provided by (Used in) Investing Activities -431K USD -242%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 3.3M shares -7.04%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.08M USD +61.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 162K USD +15.7%
Deferred Tax Assets, Valuation Allowance 90K USD -1.1%
Deferred Tax Assets, Gross 3.38M USD +8.93%
Operating Lease, Liability 1.53M USD -21.8%
Depreciation 23K USD 0%
Payments to Acquire Property, Plant, and Equipment 431K USD +242%
Lessee, Operating Lease, Liability, to be Paid 1.67M USD -23.9%
Property, Plant and Equipment, Gross 14.3M USD +6.71%
Operating Lease, Liability, Current 466K USD +9.65%
Lessee, Operating Lease, Liability, to be Paid, Year Two 551K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 404K USD -24.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 80K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 136K USD -41.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 567K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 23K USD +4.55%
Unrecognized Tax Benefits 262K USD -24.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 143K USD 0%
Operating Lease, Payments 522K USD +2.76%
Depreciation, Depletion and Amortization 302K USD +6.71%
Deferred Tax Assets, Net of Valuation Allowance 3.29M USD +9.24%
Interest Expense 152K USD +14.3%